Defining Endpoints and Biomarkers in Inflammatory Bowel Disease: Moving the Needle Through Clinical Trial Design
- PMID: 32961246
- DOI: 10.1053/j.gastro.2020.07.064
Defining Endpoints and Biomarkers in Inflammatory Bowel Disease: Moving the Needle Through Clinical Trial Design
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
